Please assess the completion status of the following clinical trial:

Trial Title: Intraductal Meibomian Gland Probing Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-89 years~* Willing and able to provide written informed consent~* Willing and able to comply with study assessments for the full duration of the study~* Diagnosis of meibomian gland dysfunction (MGD)~* Symptoms of MGD such as foreign body sensation, burning, stinging, light sensitivity for at least 3 months~* Persistent symptoms despite at least 3 months of medical management including lid hygiene, warm compress, and use of topical and systemic therapy, or contraindication to systemic therapy~* Presence of lid tenderness on the upper lids in both eyes~* Tear break-up time (TBUT) of \<10 seconds~* In good stable overall health~Exclusion Criteria:~* Active allergies to steroids, sulfacetamide, GenTeal PM Night-Time ointment, or lidocaine~* Intraocular surgery or ocular laser surgery within 1 month before enrollment~* History of ocular infection within 1 month before enrollment.~* History of increased intraocular pressure after using topical steroids (steroid responsive)~* Any condition (including language barrier) that precludes subject's ability to comply with study requirements including completion of study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Meibomian Gland Probing plus lubricant (Type: OTHER): Meibomian Gland Probing: Stainless steel probes were used to probe all the meibomian glands of upper lids of both eyes at the slit lamp. All patients were probed with a 1-mm probe followed by a 2-mm probe for all glands.~Lubricant: GenTeal PM Night-Time Ointment (Alcon), a sterile ophthalmic lubricant that is commonly used to relieve symptoms in patients with dry eye disease, was applied topically to both eyes for 4 weeks with the following regimen: twice daily for 2 weeks and then once daily for 2 weeks.
- Sham Meibomian Gland Probing plus lubricant (Type: OTHER): Sham Meibomian Gland Probing: The patient's the lid margin was touched with the probes without actual probing occurring.~Lubricant: GenTeal PM Night-Time Ointment, ophthalmic lubricant used to relieve symptoms in patients with dry eye disease, was applied topically to both eyes for 4 weeks: twice daily for 2 weeks and then once daily for 2 weeks.
- Meibomian Gland Probing plus Blephamide (Type: ACTIVE_COMPARATOR): Meibomian Gland Probing: Stainless steel probes were used to probe all the meibomian glands of upper lids of both eyes at the slit lamp. All patients were probed with a 1-mm probe followed by a 2-mm probe for all glands.~Blephamide: is a combination of an antibiotic and an anti-inflammatory agent commonly used to treat various ocular conditions. Blephamide was applied topically to both eyes for 4 weeks with a regimen of: twice daily for 2 weeks and then once daily for 2 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete